News
The rebound was fueled by Windtree Therapeutics' commitment to invest $520 million in BNB for its corporate treasury.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results